Name ↕ |
Website ↕ |
Description ↕ |
Industrial chemicals - Regulation |
http://data.europa.eu/eli/reg/2006/1907/oj |
In Europe safety of industrial chemicals is regulated in the Regulation (EC) 1907/2006 Registration, Evaluation, Authorisation and Restriction of Chemicals ( REACH). REACH addresses the production and use of chemical substances, and their potential impacts on both human health and the environment. |
Industrial chemicals - Regulation |
http://data.europa.eu/eli/reg/2018/1881/oj |
Since 2018 the European Regulation (EU) 2018/1881 amends the REACH regulation to address nanoforms. This includes additional requirements for substance identification as well as some further requirements to address the specifics of nanomaterials in their potential impacts on both human health and the environment. |
Industrial chemicals - Regulatory Guidance |
https://echa.europa.eu/guidance-documents/guidance-on-information-requirements-and-chemical-safety-assessment |
The European Chemicals Agency (ECHA) provides guidance to support registrants to comply to the REACH regulation. Since 2012 this includes specific appendices to the guidance documents that support the registration of nanoforms of a substance and providing further information on their impacts on both human health and the environment. Guidance is regularly updated to include latest scientific progress and insights. |
Cosmetics - Regulation |
http://data.europa.eu/eli/reg/2009/1223/oj |
The European Cosmetics Regulation (Regulation (EC) 1223/2009) requires Annexed cosmetic substances to be notified, safety assessed and adequately labelled before being allowed on the EU market. These annexes lay down clear limitations and requirements for the cosmetic substances concerned. The safety assessment of the cosmetic ingredients in the EU is overseen by the Scientific Committee on Consumer Safety (SCCS). |
Cosmetics - Regulatory Guidance |
https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_224.pdf |
The SCCS provides notes of guidance for the testing of cosmetic ingredients and their safety evaluation to allow companies to comply to the Cosmetics Regualtion. This notes are a living document that is regularly updated. |
Cosmetics - Regulatory Guidance |
https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_233.pdf |
In the guidance on the safety assessment of nanomaterials in cosmetics the SCCS provide detailed information and a check-list of information that an applicant should provide as a minimum for a safety assessment of nanomaterials. |
Food information - Regulation |
http://data.europa.eu/eli/reg/2011/1169/oj |
The regulation on food information to consumers (Regulation (EU) 1169/2011) requires several types of information to be indicated on the label of food prodcucts, including a clear indication of the presence of nanomaterials. |
Plant protection products - Regulation |
http://data.europa.eu/eli/reg/2013/283/oj |
The European regulation on data requirements for active substances in plant protection products (Regulation (EU) 283/2013) does not specifically mention the term "nanomaterials". Nevertheless, the data requirements should also be fulfilled for nanomaterials. |
Novel food - Regulation |
http://data.europa.eu/eli/reg/2015/2283/oj |
European regulation on novel foods (Regulation (EC) 2015/2283) |
Food additives - Regulatory Guidance |
https://doi.org/10.2903/j.efsa.2012.2760 |
EFSA guidance for submission for food additive evaluations |
Feed additives - Regulatory Guidance |
http://doi.org/10.2903/j.efsa.2019.5648 |
EFSA guidance to safety of feed additives for the environment |
Food and feed - Regulatory Guidance |
http://doi.org/10.2903/j.efsa.2021.6768 |
EFSA guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health 2021 |
Biocides - Regulation |
http://data.europa.eu/eli/reg/2012/528/oj |
European regulation on biocidal products (Regulation (EU) 528/2012) |
Biocides - Regulatory Guidance |
https://echa.europa.eu/guidance-documents/guidance-on-biocides-legislation |
ECHA guidance for biocidal products. |
Medicinal products - Regulation |
http://data.europa.eu/eli/dir/2001/83/oj |
European directive on directive medicinal products for human use (Directive (EC) 2001/83) |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/ich-q6a-specifications-test-procedures-acceptance-criteria-new-drug-substances-new-drug-products |
EMA note for guidance on test procedures for new drugs (chemical substances) |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/carcinogenic-potential |
EMA note for guidance on testing carcinogenic potential |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/non-clinical-investigation-dependence-potential-medicinal-products |
EMA guideline on the non-clinical investigation of the dependence potential of medicinal products |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/ich-s8-immunotoxicity-studies-human-pharmaceuticals |
EMA note for guidance on immunotoxicity studies for human pharmaceuticals |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/environmental-risk-assessment-medicinal-products-human-use |
EMA guideline on environmental risk assessment of medicinal products for human use |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/ich-s2-r1-genotoxicity-testing-data-interpretation-pharmaceuticals-intended-human-use |
EMA note for guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/risk-assessment-medicinal-products-human-reproduction-lactation-data-labelling |
EMA guideline on risk assessment of medicinal products on human reproduction and lactation |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/need-non-clinical-testing-juvenile-animals-human-pharmaceuticals-paediatric-indications |
EMA guideline on the need for non-clinical testing in juvenile animals on human pharmaceuticals for paediatric indications |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/repeated-dose-toxicity |
EMA guideline on repeated dose toxicity |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/documents/scientific-guideline/joint-ministry-health-labour-welfare/european-medicines-agency-reflection-paper-development-block-copolymer-micelle-medicinal-products_en.pdf |
MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/data-requirements-intravenous-liposomal-products-developed-reference-innovator-liposomal-product |
EMA reflection paper on the data requirements for intravenous liposomal products |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/ich-s10-photosafety-evaluation-pharmaceuticals |
EMA guidance on photosafety evaluation of pharmaceuticals |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/non-clinical-local-tolerance-testing-medicinal-products |
EMA guideline on non-clinical local tolerance testing of medicinal products |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/data-requirements-intravenous-iron-based-nano-colloidal-products-developed-reference-innovator |
EMA reflection paper on the data requirements for intravenous iron-based nano-colloidal products |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-chemistry-active-substances_en.pdf |
EMA guideline on the chemistry of active substances |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/requirements-chemical-pharmaceutical-quality-documentation-concerning-investigational-medicinal |
EMA guideline on the chemical and pharmaceutical quality in clinical trials |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-environmental-risk-assessment-medicinal-products-human-use-revision-1_en.pdf |
EMA guideline on the environmental risk assessment of medicinal products for human use |
Medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/ich-s5-r3-guideline-reproductive-toxicology-detection-toxicity-reproduction-human-pharmaceuticals |
EMA guideline on reproductive toxicology for human pharmaceuticals |
Medical devices - Regulation |
http://data.europa.eu/eli/reg/2017/745/oj |
European regulation on medical devices (Regulation (EU) 2017/745) |
Medical devices - Regulatory Guidance |
https://ec.europa.eu/health/scientific_committees/consultations/public_consultations/scenihr_consultation_22_nl |
SCENIHR guidance on nanomaterials in medical devices |
Medical devices - Regulatory Guidance |
https://www.iso.org/standard/35979.html |
ISO guidance on immunotoxicology testing of medical devices |
Medical devices - Regulatory Guidance |
https://www.iso.org/standard/36406.html |
ISO guidance on tests for in vitro cytotoxicity of medical devices |
Medical devices - Regulatory Guidance |
https://www.iso.org/standard/55614.html |
ISO guidance on tests for genotoxicity, carcinogenicity and reproductive toxicity of medical devices |
Medical devices - Regulatory Guidance |
https://www.iso.org/standard/68426.html |
ISO guidance on tests for systemic toxicity of medical devices |
Medical devices - Regulatory Guidance |
https://www.iso.org/standard/65918.html |
ISO guidance on biological evaluation of nanomaterials in medical devices |
Medical devices - Regulatory Guidance |
https://www.iso.org/standard/75279.html |
ISO guidance on tests for skin sensitization of medical devices |
Medical devices - Regulatory Guidance |
https://www.iso.org/standard/74151.html |
ISO guidance on tests for irritation of medical devices |
Veterinary medicinal products - Regulation |
http://data.europa.eu/eli/reg/2019/6/oj |
European regulation on veterinary medicinal products (Regulation (EU) 2019/6) |
Veterinary medicinal products - Regulation |
http://data.europa.eu/eli/reg_del/2021/805/oj |
Amendment of Annex II of the European regulation on veterinary medicinal products (Delegated Regulation (EU) 2021/805) |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/vich-gl22-safety-studies-veterinary-drug-residues-human-food-reproduction-studies |
EMA guidance on reproduction testing of residues of veterinary drugs in human food |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/vich-gl31-safety-studies-veterinary-drug-residues-human-food-repeat-dose-90-toxicity-testing |
EMA guidance on repeated-dose 90 day toxicity testing of residues of veterinary drugs in human food |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/vich-gl37-safety-veterinary-drugs-human-food-repeat-dose-chronic-toxicity-testing |
EMA guidance on repeated-dose chronic toxicity testing of residues of veterinary drugs in human food |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/documents/scientific-guideline/vich-gl38-environmental-impact-assessments-veterinary-medicinal-products-vmps-phase-ii_en.pdf |
EMA guidance on environmental impact assessment for veterinary medicinal products |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/documents/scientific-guideline/vich-gl28-studies-evaluate-safety-veterinary-drugs-human-carcinogenicity-testing-step-7-after_en.pdf |
EMA guidance on human carcinogenicity testing of veterinary drugs |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/vich-gl33-safety-studies-veterinary-drug-residues-human-food-general-approach-testing |
EMA guidance on a testing approach for residues of veterinary drugs in human food |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/determining-fate-veterinary-medicinal-products-manure |
EMA guidance on determining fate of veterinary medicinal products in manure |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/documents/scientific-guideline/vich-gl23-studies-evaluate-safety-residues-veterinary-drugs-human-food-genotoxicity-testing-revision_en.pdf |
EMA guidance on genotoxicity testing of residues of veterinary drugs in human food |
Veterinary medicinal products - Regulatory Guidance |
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/advice-implementing-measures-under-article-1462-regulation-eu-2019/6-veterinary-medicinal-products-scientific-recommendation-revision-annex-ii-regulation-eu-2019/6-veterinary-medicinal-products_en.pdf |
EMA advice on implementing the European regulation on veterinary medicinal products |
United States of America - Toxic Substances Control Act |
https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/control-nanoscale-materials-under |
In the United States of America nanoscale materials are assessed within the regulatory framework for chemicals in the Toxic Substances Control Act. An information gathering rule on new and existing nanomaterials is drafted and premanufacture notifications for new nanomaterials have become mandatory. |
Canada Environmental Protection Act |
https://www.canada.ca/en/health-canada/services/chemical-substances/nanomaterials.html |
In Canada nanoscale materials are assessed within the regulatory framework for chemicals in the Canada Environmental Protection Act. In June 2022, a draft Framework for the Risk Assessment of Manufactured Nanomaterials under the Canadian Environmental Protection Act was published. In parallel to developing this Framework the Government of Canada initiated screening assessments of some identified existing nanomaterials. |
Australian Industrial Chemicals Introduction Scheme (AICIS) |
https://www.industrialchemicals.gov.au/help-and-guides/extra-resources-help-you-categorise-your-introduction/categorisation-chemicals-nanoscale |
Anyone who plans to manufacture or import industrial chemicals (or products that contain industrial chemicals) into Australia for commercial, research or any business-related purposes needs to register to enable assessment and authorisation by the Australian government. |
K-REACH |
https://www.kei.re.kr/board.es?mid=a20603000000&bid=0063&list_no=57894&act=view |
“Korea’s Act on the Registration and Evaluation of Chemical Substances” is the legislation that sets out the rules on how to register, evaluate and safely manage chemicals. Specific requirements are included for nanomaterials. |